Correlation Between Onyx Acquisition and Regeneron Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Onyx Acquisition and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Onyx Acquisition and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Onyx Acquisition Co and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Onyx Acquisition and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Onyx Acquisition with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Onyx Acquisition and Regeneron Pharmaceuticals.

Diversification Opportunities for Onyx Acquisition and Regeneron Pharmaceuticals

0.27

Correlation Coefficient

Onyx Acquisition  Regeneron Pharmaceuticals

Modest diversification

The 3 months correlation between Onyx and Regeneron is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Onyx Acquisition Co and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Onyx Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Onyx Acquisition Co are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Onyx Acquisition i.e., Onyx Acquisition and Regeneron Pharmaceuticals go up and down completely randomly.

Pair Corralation between Onyx Acquisition and Regeneron Pharmaceuticals

Assuming the 90 days horizon Onyx Acquisition Co is expected to generate 0.4 times more return on investment than Regeneron Pharmaceuticals. However, Onyx Acquisition Co is 2.52 times less risky than Regeneron Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.39 per unit of risk. If you would invest  1,121  in Onyx Acquisition Co on September 18, 2024 and sell it today you would earn a total of  10.00  from holding Onyx Acquisition Co or generate 0.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	58.73%
Values	Daily Returns

Onyx Acquisition Co  vs.  Regeneron Pharmaceuticals

Onyx Acquisition

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Onyx Acquisition Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Onyx Acquisition is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Regeneron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Onyx Acquisition and Regeneron Pharmaceuticals

The main advantage of trading using opposite Onyx Acquisition and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Onyx Acquisition position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.

The idea behind Onyx Acquisition Co and Regeneron Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.